Welcome to our dedicated page for Siriuspoint SEC filings (Ticker: SPNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SiriusPoint Ltd. (SPNT) SEC filings page on Stock Titan brings together the company’s U.S. regulatory disclosures, including current reports on Form 8-K and other key documents filed with the Securities and Exchange Commission. SiriusPoint is a Bermuda-incorporated global underwriter of insurance and reinsurance whose common shares and 8.00% Resettable Fixed Rate Preference Shares, Series B, are listed on the New York Stock Exchange under the symbols SPNT and SPNT PB. Its filings provide detailed insight into segment performance, capital structure, governance, and material corporate events.
Through its Form 8-K filings, SiriusPoint reports results of operations and financial condition, furnishing earnings press releases, financial supplements, and investor presentations for periods such as the second and third quarters. These documents explain Core results across the Insurance & Services and Reinsurance segments, combined ratios, underwriting income, Core net services income, and book value measures, as well as the impact of catastrophe losses and prior-year reserve development.
The company also uses Form 8-K to disclose material transactions and strategic actions, including the definitive agreement and subsequent completion of the sale of ArmadaCorp Capital, LLC, the holding company of supplemental health insurance program manager ArmadaCare, and the agreement to sell its equity stake in Arcadian Holdings Limited to an acquisition vehicle affiliated with Lee Equity Partners. Related exhibits often include press releases describing associated capacity agreements that extend underwriting authority for Arcadian through at least the end of 2031.
Additional filings cover governance and compensation matters, such as the adoption of the SiriusPoint Ltd. Executive Severance Plan, appointments and resignations of executive officers and directors, and determinations about director independence. SiriusPoint also files 8-Ks to announce quarterly cash dividends on its Series B preference shares, specifying dividend amounts, record dates, and payment dates.
On Stock Titan, these SEC filings are updated as they are released on EDGAR, and AI-powered summaries can help explain the significance of each report. Users can quickly see which filings relate to earnings (such as 10-Q and 10-K when available), which detail insider and executive changes, and which describe major transactions or capital actions, providing a structured view of SiriusPoint’s regulatory history.
SiriusPoint Ltd. has announced the full redemption of all 8,000,000 of its 8.00% Resettable Fixed Rate Preferred Shares, Series B. The redemption will occur on February 26, 2026, retiring this entire preferred share series.
The company also stated its intent to delist and deregister the Series B Preference Shares from the New York Stock Exchange and under U.S. securities laws. These steps consolidate its capital structure by removing this listed preferred security from public trading.
SiriusPoint Ltd’s chief executive officer and director Scott Egan reported an internal transfer of 545,083 common shares of SiriusPoint on 12/19/2025. The shares moved from his direct ownership to indirect ownership through Egan Family Investment Ltd., a UK family investment company, for estate planning purposes, and the filing states that no consideration was paid for the transfer.
After the transactions, Egan directly owns 239,083 common shares, and indirectly owns 545,083 common shares through Egan Family Investment Ltd. The filing notes that these holdings include restricted shares.
SiriusPoint Ltd insider Scott Egan, the company’s Chief Executive Officer and a director, reported a transaction involving company common shares. On 12/12/2025, 21,801 common shares were recorded in a transaction coded F.
The filing explains that these shares were withheld to cover current tax liabilities in connection with the vesting of restricted share units. Following this transaction, Egan directly beneficially owns 784,166 SiriusPoint common shares, which the filing notes include restricted shares.
A shareholder of the SPNT issuer has filed a Rule 144 notice to sell 37,311 shares of common stock. The sale is planned to occur around 12/12/2025 on the NYSE through J.P. Morgan Securities LLC. Based on the filing, the aggregate market value of the shares to be sold is $831,289.08, compared with 116,814,640 shares of the same class outstanding. The shares were originally acquired on 12/31/2012 as a gift from Clare Loeb, who had acquired the shares earlier. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
SiriusPoint Ltd. executive David E. Govrin, Group President, reported a share transaction involving company common shares. On 11/30/2025, 52,800 common shares were withheld at a price of $0 under transaction code "F", which indicates shares were withheld to cover current tax liabilities tied to the vesting of restricted shares. Following this transaction, he beneficially owned 517,975 common shares, which include restricted shares. The reported holdings were also adjusted to correct a prior overstatement by 6,570 shares.
SiriusPoint Ltd. reported an insider equity transaction by its Group Chief Underwriting Officer, Anthony Shapella. On 11/30/2025, 2,375 common shares were withheld with a transaction code "F," which indicates shares were surrendered to cover current tax liabilities related to the vesting of restricted shares. The price is shown as $0 because this is a tax withholding event rather than an open-market sale or purchase.
After this transaction, Shapella beneficially owned 42,215 common shares, which the disclosure notes include restricted shares. This type of activity is administrative in nature and reflects routine handling of taxes when equity awards vest.
Donald Smith & Co., Inc. filed a Schedule 13G reporting a passive stake in SiriusPoint Ltd (SPNT). The filer reports 7,402,682 shares beneficially owned, representing 6.34% of the common stock as of the event date 09/30/2025.
The filing lists sole voting power over 7,135,119 shares for Donald Smith & Co., Inc. and 63,073 shares for DSCO Value Fund, L.P., and sole dispositive power over 7,339,609 shares for Donald Smith & Co., Inc. and 63,073 shares for DSCO Value Fund, L.P. The certification states the securities were acquired and are held in the ordinary course and not to change or influence control.
Capital Research Global Investors filed a Schedule 13G reporting beneficial ownership of 6,700,000 shares of SiriusPoint Ltd. (SPNT), representing 5.7% of the class as of the event date September 30, 2025.
The filer reports sole voting power: 6,700,000 and sole dispositive power: 6,700,000, with no shared voting or dispositive power. The percentage is based on 116,759,539 shares believed outstanding. The certification states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
Wellington Management Group LLP, together with affiliated entities, filed an amended Schedule 13G reporting beneficial ownership in SiriusPoint Ltd. (SPNT).
They reported 4,297,864 shares beneficially owned, representing 3.68% of the common stock, as of the event date 09/30/2025. Wellington reported 0 shares with sole voting or dispositive power, 3,321,795 shares with shared voting power, and 4,297,864 shares with shared dispositive power.
The shares are owned of record by clients of Wellington’s investment adviser affiliates. Wellington stated that no single client is known to have rights to more than five percent of the class and certified the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
SiriusPoint Ltd. completed the previously announced sale of all membership interests in ArmadaCorp Capital, LLC, the holding company of its supplemental health insurance program manager ArmadaCare, to a subsidiary of Ambac Financial Group Inc.
The Seller received $250 million in cash consideration, subject to deductions including transaction expenses. The transaction closed after satisfaction of customary closing conditions.